Ying Peng

Successful treatment by Thalidomide therapy of intestinal Behçet's disease associated with Trisomy 8 myelodysplastic syndrome.

Shuangnian Xu, Yonghong He, Xingyue Zhang, 2020, Rheumatology.

SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surface

J. Boyer, M. Zheng, Wen-Yue Liu, 2022, JCI insight.

The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review

Xin-chan Feng, Wensheng Chen, Yonghong He, 2018, Expert review of gastroenterology & hepatology.

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review

Hong Yang, Ying Peng, Qiaoling Xie, 2020, European journal of gastroenterology & hepatology.

Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy

Yun Liu, Hongbo Wu, Qinglin Wei, 2021, Gastroenterology research and practice.

ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review

Wensheng Chen, Yonghong He, Jingjing Zhao, 2020, Expert review of gastroenterology & hepatology.

Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis

J. Boyer, Xuequan Huang, Xiaoxun Zhang, 2023, Nature Communications.

Association between body fat composition and disease duration, clinical activity, and intravenous corticosteroid-induced response in inflammatory bowel disease

Ying Peng, Jin Chai, Shubei He, 2023, Lipids in Health and Disease.

Causality between inflammatory bowel disease and the cerebral cortex: insights from Mendelian randomization and integrated bioinformatics analysis

Y. Ou, Ying Peng, Xiaofang Chen, 2023, Frontiers in immunology.